PPP1R13L and posterior cortical atrophy: Increased expression of two p53 inhibitors, mouse double minute 2 homologue and inhibitor of apoptosis-stimulating protein of p53 (iASPP), is responsible for the inactivation of wild-type p53 in human malignant melanoma25 which, like PCa, has a low rate of p53 mutation.